Philippe Peltier

Philippe joined Kurma in July 2015. Philippe was previously a Partner with Auriga Partners from 1999 and 2015 and conducted several investments in Life Sciences in Europe and in the USA.

He is also a board member of DNA Script (France), Damae Medical (France), Sensome (France) and Cardiologs (France). Philippe holds a MS in molecular biology (Paris 7 University) and MS in Finance (ESSEC).